Share
Export Citation
APA
MLA
Chicago
Harvard
Vancouver
BIBTEX
RIS
Universitas Hasanuddin
Research output:Contribution to journal›Article›peer-review
Association of ERα-36 expression with the de novo resistance of tamoxifen in ER-positive breast cancer
Juliansyah A.
Breast Disease
Q3Published: 2021Citations: 5
Abstract
There was an association between the expression of ER-α36 with de novo resistance of tamoxifen in ER-positive breast cancer. ER-α36 could act as a worth considering biomarker for de novo resistance of tamoxifen in therapeutic strategies.
Access to Document
10.3233/BD-219019Other files and links
Fingerprint
TamoxifenSciences
Breast cancerSciences
MedicineSciences
OncologySciences
Internal medicineSciences
Estrogen receptorSciences
CancerSciences
ImmunohistochemistrySciences
BiomarkerSciences
GynecologySciences
BiologySciences
BiochemistrySciences